This week, host Andrew Maddigan, Vice President of Client Engagement, welcomes CSI Specialty Group's Richard H. Williams, RPh, to discuss key pharmaceutical trends to be aware of post-coronavirus and what opportunities may present themselves as the country begins a return to normalcy.

This week, host Andrew Maddigan, Vice President of Client Engagement, welcomes Senior Director of Supply Chain Consulting for CSI Specialty Group Ken Cyr. Ken joins the program to discuss how the healthcare supply chain industry has changed over his 25 years in the business and what opportunities are now available following the COVID-19 pandemic.

CSI Specialty Group's Richard H. Williams, RPh, joins host Andrew Maddigan to discuss how pharmaceutical manufacturers are working together in an unprecedented way to help address the Coronavirus crisis.

This week, host Andrew Maddigan, Vice President of Client Engagement, welcomes CSI Senior Consultant, Vijeev Menon, to break down the accreditation process in specialty pharmacy and illustrate how organizations, especially first-time applicants, can best prepare for success.

This week, Richard Williams, R.Ph., Senior Vice President of Pharmaceutical Innovation and Insights at CSI Specialty Group, joins host Andrew Maddigan, Vice President, Client Engagement, to discuss the most impactful upcoming meetings and conferences in 2020 and how specialty pharmacy stakeholders can decide what events might be right for them to consider.

This week, Richard Williams, R.Ph., Senior Vice President of Pharmaceutical Innovation and Insights at CSI Specialty Group, joins host Andrew Maddigan, Vice President, Client Engagement, to recap key takeaways from January’s 38th Annual J.P. Morgan Healthcare Conference from San Francisco, CA.

Don’t miss this overview featuring some of the major trends and announcements from industry leaders, emerging tech companies and private equity/investment firms at one of the year’s most influential healthcare conferences.

Biosimilars will be a critical element of the future of healthcare in the United States. Already in Europe, biosimilars have been widely adopted, allowing the European Union to save substantial amounts of money on healthcare.

In this special centennial episode, Richard Williams, R.Ph., Senior Vice President of Pharmaceutical Innovation and Insights at CSI Specialty Group, joins host Andrew Maddigan, Vice President, Client Engagement, to share new insights on the topic of pharmaceutical biosimilars.

In this episode, Richard Williams, R.Ph., Senior Vice President of Pharmaceutical Innovation and Insights at CSI Specialty Group, joins host Andrew Maddigan, Vice President, Client Engagement, to share new insights on a busy fall conference season.

Richard also breaks down the strategic priorities facing hospital pharmacies, Washington’s inertia on pharmacy policy, and the future of technology and healthcare.

Accreditation continues to be both relevant and essential for specialty pharmacies who want to earn a “seat at the table” and gain access to payor networks and specialty medication manufacturers.

This week, host Andrew Maddigan, Vice President of Client Engagement, welcomes Vijeev Menon, Director of Specialty Pharmacy Consulting and Accreditation at CSI Specialty Group to dissect the role of accreditation in specialty pharmacy, reveal current trends, and propose methods to assist specialty pharmacies in their preparation for the accreditation process.